COMPANY PROFILE

Nudge

Explore full profile

Non-invasive neuromodulation headset enhancing brain function through precise stimulation and imaging

San Francisco, United StatesFounded 2025Health Tech & Medtech

Valuation $500M–1B Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Nudge

Nudge operates in the neurological health sector, focusing on developing a non-invasive neuromodulation headset designed to enhance brain function. The company targets individuals seeking to improve their cognitive abilities and overall brain health. By leveraging focused ultrasound technology, Nudge aims to provide a product that can precisely stimulate and image the brain, offering potential benefits for treating neurological disorders and enhancing daily human experiences. The business model likely involves direct sales to consumers or partnerships with healthcare providers, generating revenue through the sale of its advanced headsets. Nudge's multidisciplinary team is dedicated to creating cutting-edge technology that interfaces with the entire brain, positioning itself as a key player in the brain health market.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2025
Headquarters: San Francisco, United States
Employees: 38
Open positions: 5
Dealroom signal: 93.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Neurology, Neuromodulation and Neurostimulation, Non-Invasive medical devices and treatments, DT and LS, science-based
Technology: Deep Tech, Connected Device
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Jul 2025	$100M	$400M	Greenoaks Capital Partners · Thrive Capital	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Nudge website traffic

Latest recorded traffic for Nudge is 12K monthly website visits, down 33.3% over the last three months. Nudge's team grew 18.8% over the past year.

Latest monthly visits12K 3-month web change-33.3% 1-year team growth+18.8%

Monthly website visitsDec 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Clinical Research Operations ManagerSan Francisco, California, United States, Northern America, Americas · Other · Sep 4, 2026 Finance Operations ManagerSan Francisco, California, United States, Northern America, Americas · Finance · Sep 4, 2026 Materials EngineerSan Francisco, California, United States, Northern America, Americas · Other · Sep 4, 2026 Machine Learning EngineerSan Francisco, California, United States, Northern America, Americas · Data Science & Engineering · Aug 21, 2026 Session OperatorSan Francisco, California, United States, Northern America, Americas · Backend Development · Jul 10, 2026 Member of Research Staff, PreclinicalSan Francisco, CA · Other · Jul 2, 2026 Engineering TechnicianSan Francisco, California, United States · Other · Jan 9, 2026 Lead RecruiterSan Francisco, California, United States · Human Resources · Oct 28, 2025

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NENeuroliefDevelops proprietary digital theraputics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression	Netanya, Israel	Operational	32	$18M	—
GEGestalaNon-invasive ultrasound brain-computer interface technology.	Chengdu, China	Operational
AMAmpaPortable neuromodulation system for treating major depressive disorder	Palo Alto, United States	Operational
XTXi'an Dome Medical TechnologyNon-invasive deep brain neuromodulation for neurological disorders	China	Operational
NHNoctrix HealthEarly-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness	Pleasanton, United States	Acquired
STSinaptica TherapeuticsClinical-stage company that has developed a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease	Cambridge, United States	Operational
NENeurovalensNon-invasive neurostimulation devices for treating chronic conditions.	Belfast, United Kingdom	Operational
NTNIBS NeuroScience TechnologiesImaging algorithm system for monitoring brain disorders	Tzur Moshe, Israel	Operational